Atropine Sulfate
Product Images NDC 51662-1339

7 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Atropine Sulfate (NDC 51662-1339). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Adverse 1 (Adverse 1)

Adverse 1 (Adverse 1)
A data table listing symptoms associated with varying doses of Atropine Sulfate ranging from 0.5 mg to 65 mg. Symptoms increase in severity with dose, from slight dryness of nose and mouth and bradycardia at 0.5 mg, to dryness, tachycardia, and visual disturbances at 2 mg, speech and swallowing difficulties and restlessness at 5 mg, extreme symptoms including ataxia and coma at 10 mg and over, and potential fatality at 65 mg.*
FDA Label Image

Dosage (Dosage 1)

Dosage (Dosage 1)
A dosage chart table showing weight ranges in pounds paired with corresponding Atropine Sulfate dosages in milligrams. The table lists specific dose values for weight brackets from 7-16 pounds up to over 90 pounds, detailing dosages ranging from 0.1 mg to 0.6 mg.*
FDA Label Image

How Supplied (How Supplied)

How Supplied (How Supplied)
A table listing multiple Atropine Sulfate products with their NDC numbers, concentrations, and vial/ampule sizes. It shows four different product configurations with concentrations of 0.4 mg/0.5 mL, 1.0 mg/1 mL, and packaging formats including ampules and single-dose vials, each packed in boxes of 25 units.*
FDA Label Image

Labeled Vial (Labeled Vial)

Labeled Vial (Labeled Vial)
Atropine Sulfate Injection, USP vial shows a 1 mL single dose vial containing 0.4 mg/mL of the active ingredient. The vial has a green cap and is labeled for intravenous, intramuscular, or subcutaneous use. The label also states the product is preservative free and for prescription use only.*
FDA Label Image

Serialized Vial Labeling (Serialized Vial Label)

Serialized Vial Labeling (Serialized Vial Label)
ATROPINE SULFATE 0.4 mg/mL injection vial with teal cap, labeled as a 1 mL single dose vial for IV, IM, or SC use, preservative-free. Distributed by HF Acquisition Co LLC, DBA HealthFirst. Includes a barcode and regulatory text on an attached label indicating NDC 0517-0401-25.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram showing the molecular formula C17H23NO3 and molecular weight 289.37 of atropine sulfate, illustrating the arrangement of its atoms and bonds including nitrogen, carbon, hydrogen, and oxygen.*
FDA Label Image

Vial Label (Vial Label R)

Vial Label (Vial Label R)
Label for ATROPINE SULFATE injection USP, 0.4 mg per mL, single dose vial by HF Acquisition Co LLC, DBA HealthFirst. The label includes storage instructions, dosage form, and a barcode. The cap color indication is also shown as a teal circle.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.